A 67-year-old man with acute anterolateral myocardial infarction had recurrent ventricular fibrillation that required insertion of temporary pacemaker. When a permanent pacemaker was inserted stable ...
Patients who received a leadless pacemaker had similar rates of acute complications and survival at 30 days as those who received a transvenous VVI pacemaker, according to data presented at the ...
Patients with intracardiac shunts might at some point require a pacemaker or an implantable cardioverter–defibrillator (ICD). These patients may have numerous thrombotic risk factors, however, and ...
Please provide your email address to receive an email when new articles are posted on . “Prior research has established the subcutaneous ICD as a reasonable alternative to the transvenous ICD in ...
Despite being at higher risk of complications overall, Medicare beneficiaries who receive a Micra leadless pacemaker (Medtronic) fare better than those implanted with traditional transvenous systems, ...
Patients receiving leadless pacemakers experience overall fewer short-term and mid-term complications than those receiving traditional transvenous pacemakers, a new study found. Patients receiving ...
There are unique technical issues that must be considered with the implantation of devices in small patients and those with CHD. Although most centers report low complication rates of complications in ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- A ...
MidMichigan's Heart and Vascular Program is now offering a new miniature leadless pacemaker implant for qualified patients with permanent atrial fibrillation. The MicraTM Transcatheter Pacing System, ...
Leadless pacemaker technology represents a significant advancement in cardiac rhythm management, eliminating the need for transvenous leads and reducing many of the complications associated with ...
The implantable defibrillator with subcutaneous leads, designed in part to minimize the risk for potentially serious lead-related complications, has reached a milestone by turning in a "noninferior" ...